it seems lower doses accelerate disease progression on some biomarkers, and PGIC.
The std dev on the presentations suggest the 2mg/kg has some big nett negative effect on some patients. Std dev is 2 sigma - so I now understand the FDA hesitancy. it’s not one rat.
it seems lower doses accelerate disease progression on some...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $94.44M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 27.0¢ | $127.7K | 460.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 287444 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 100870 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
-0.010 ( 5.69 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 29.0¢ | 27.0¢ | 132157 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| PAR (ASX) Chart |